BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27425855)

  • 1. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Wetmore JB; Guo H; Liu J; Collins AJ; Gilbertson DT
    Kidney Int; 2016 Oct; 90(4):853-60. PubMed ID: 27425855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics and outcomes by GN subtype in ESRD.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
    Lopes AA
    Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of glomerulonephritis and non-diabetic end-stage renal disease in a developing middle-east region near armed conflict.
    Ali AA; Sharif DA; Almukhtar SE; Abd KH; Saleem ZSM; Hughson MD
    BMC Nephrol; 2018 Oct; 19(1):257. PubMed ID: 30305040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
    OʼShaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Transplantation; 2017 Oct; 101(10):2636-2647. PubMed ID: 28207635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?
    Haider DG; Masghati S; Goliasch G; Fuhrmann V; Soleiman A; Wolzt M; Baierl A; Druml W; Hörl WH
    J Nephrol; 2014 Dec; 27(6):643-51. PubMed ID: 24609889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Outcomes of Patients With Pregnancy-Related End-Stage Kidney Disease.
    Kucirka LM; Angarita AM; Manuck TA; Boggess KA; Derebail VK; Wood ME; Meyer ML; Segev DL; Reynolds ML
    JAMA Netw Open; 2023 Dec; 6(12):e2346314. PubMed ID: 38064217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer development and mortality differences in patients with glomerulonephritis after renal biopsy: a single center retrospective cohort study.
    Ryu H; Kim K; Ryu J; Son HE; Ryu JY; Kim S; Na KY; Chae DW; Chin HJ;
    BMC Nephrol; 2020 Jun; 21(1):221. PubMed ID: 32522167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
    Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
    Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
    JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing access to cardiovascular procedures in patients with chronic kidney disease: race, sex, and insurance.
    Daumit GL; Powe NR
    Semin Nephrol; 2001 Jul; 21(4):367-76. PubMed ID: 11455525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplantation Outcomes across GN Subtypes in the United States.
    O'Shaughnessy MM; Liu S; Montez-Rath ME; Lenihan CR; Lafayette RA; Winkelmayer WC
    J Am Soc Nephrol; 2017 Feb; 28(2):632-644. PubMed ID: 27432742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Differences and Factors Associated with Pregnancy in ESKD Patients on Dialysis in the United States.
    Shah S; Christianson AL; Meganathan K; Leonard AC; Schauer DP; Thakar CV
    J Am Soc Nephrol; 2019 Dec; 30(12):2437-2448. PubMed ID: 31554657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
    Chou YH; Lin WC; Chen YM
    Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
    Hsu CY; Lin F; Vittinghoff E; Shlipak MG
    J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.